Roth Capital Remains Positive on Galena Biopharma (GALE) Following Zuplenz Launch

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. SPY
7. CVS
8. UNH
9. TMUS
10. VZ

Go back to Roth Capital Remains Positive on Galena Biopharma (GALE) Following Zuplenz Launch

Galena Biopharma Launches Zuplenz(R) (ondansetron) Oral Soluble Film

July 29, 2015 7:05 AM EDT

Zuplenz is indicated for the prevention of chemotherapy-induced nausea and vomiting (CINV), radiotherapy-induced nausea and vomiting (RINV), and post-operative nausea and vomiting (PONV) Novel, oral soluble film technology provides convenient delivery and key patient benefits

PORTLAND, Ore., July 29, 2015 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ: GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, today announced the product launch for Zuplenz® (ondansetron) Oral Soluble Film in the United States.

Zuplenz is now... More